By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Topigen Pharmaceuticals Inc. 

2901 Rachel, Suite 13

Montreal  Quebec  H1W 4A4  Canada
Phone: 514-868-0077 Fax: 514-868-0011


SEARCH JOBS


Industry
Biotechnology






Company News
NicOx SA (NCOX.F) and Topigen Pharmaceuticals Inc. Terminate Collaboration Following the Acquisition of TOPIGEN by Pharmaxis Ltd (PXS.AX) 1/12/2010 7:15:30 AM
Pharmaxis Ltd (PXS.AX) to Acquire Topigen Pharmaceuticals Inc. 1/12/2010 6:56:49 AM
Topigen Pharmaceuticals Inc. Reports Phase 2 Results of TPI ASM8 in Asthma Patients 1/9/2009 10:27:09 AM
Topigen Pharmaceuticals Inc. Completes Formation of New Management Team With the Appointment of Robert Boisjoli as Chief Financial Officer 1/9/2009 10:15:58 AM
Topigen Pharmaceuticals Inc. Moves Novel Inhaled PDE Inhibitor, TPI 1100, Into Clinical Development for COPD 12/23/2008 9:44:08 AM
Topigen Pharmaceuticals Inc. To Present At Two Upcoming Medical Conferences 9/29/2008 12:17:16 PM
Topigen Pharmaceuticals Inc. Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer 8/14/2008 7:13:06 AM
Topigen Pharmaceuticals Inc. Completes Enrollment of Phase II Clinical Study of TPI ASM8 in Asthma 7/23/2008 8:25:59 AM
Topigen Pharmaceuticals Inc. Appoints Jeremy Curnock Cook to Its Board of Directors 6/3/2008 10:32:06 AM
Topigen Pharmaceuticals Inc. Announces Management Changes; Search for New CEO and CFO Begins 3/5/2008 3:55:23 PM
123456
//-->